Thermo Fisher Scientific (TMO) Total Debt (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Debt for 18 consecutive years, with $45.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt rose 22.57% year-over-year to $45.7 billion; the trailing twelve-month figure through Jun 2026 stood at $45.7 billion (up 22.57% YoY), and the FY2025 full-year result was $42.7 billion, up 28.3% from the prior year.
• Total Debt eased to $45.7 billion in Q2 2026 per TMO's latest filing, from $46.0 billion in the prior quarter.
• Across five years, Total Debt topped out at $46.0 billion in Q1 2026 and bottomed at $30.0 billion in Q4 2022.
• Historically, Total Debt has averaged $38.6 billion across 5 years, with a median of $39.3 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Debt surged 87.28% in 2022, then decreased 13.17% in 2024.
• Over 5 years, Total Debt stood at $39.9 billion in 2022, then fell by 3.82% to $38.3 billion in 2023, then fell by 13.17% to $33.3 billion in 2024, then advanced by 28.3% to $42.7 billion in 2025, then increased by 6.9% to $45.7 billion in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $45.7 billion, $46.0 billion, and $42.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.